NCT05125354View on ClinicalTrials.gov

A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT

CompletedOBSERVATIONAL

Enrollment

33

Participants

Timeline

Start Date

January 6, 2022

Primary Completion Date

March 6, 2022

Study Completion Date

March 6, 2022

Conditions

Squamous Cell CarcinomaDaRT Treated Patients

Trial Locations (2)

49100

Davidof Cancer Institution at the Rabin Medical Center Israel, Petah Tikva

Unknown

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola

Sponsors

Lead Sponsor

Alpha Tau Medical LTD.

All Listed Sponsors

lead

Alpha Tau Medical LTD.

INDUSTRY

NCT05125354 - A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT | Biotech Hunter | Biotech Hunter